Assembly Biosciences to Present at the Jefferies London Healthcare Conference Wed, 08 Nov 2017 12:00:00 +0000 INDIANAPOLIS, Nov. 08, 2017-- Assembly Biosciences, Inc., a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel oral ...
Assembly Biosciences Announces Pricing of $60 Million Offering of Common Stock Thu, 02 Nov 2017 04:40:53 +0000 INDIANAPOLIS, Nov. 02, 2017-- Assembly Biosciences, Inc., a clinical-stage biotechnology company advancing a new class of oral therapeutic candidates for the treatment of hepatitis B virus infection and ...
Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock Wed, 01 Nov 2017 20:01:00 +0000 INDIANAPOLIS, Nov. 01, 2017-- Assembly Biosciences, Inc., a clinical-stage biotechnology company advancing a new class of oral therapeutic candidates for the treatment of hepatitis B virus infection and ...
Assembly Biosciences, Inc. – Value Analysis (NASDAQ:ASMB) : October 26, 2017 Thu, 26 Oct 2017 15:01:04 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Assembly Biosciences, Inc. a score of 33. Our analysis is based on comparing Assembly Biosciences, Inc. with the following peers – Ironwood Pharmaceuticals, Inc. Class A, Ocera Therapeutics, Inc., Synergy Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., Enzon Pharmaceuticals, Inc., Orexigen Therapeutics, Inc., Progenics Pharmaceuticals, Inc. and Sucampo Pharmaceuticals, ... Read more
(Read more...)
Assembly Biosciences, Inc. breached its 50 day moving average in a Bearish Manner : ASMB-US : October 25, 2017 Wed, 25 Oct 2017 12:14:43 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Assembly Biosciences, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
(Read more...)
Assembly Biosciences Announces 2017 AASLD Presentations Mon, 02 Oct 2017 11:00:00 +0000 INDIANAPOLIS, Oct. 02, 2017-- Assembly Biosciences, Inc., a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel oral ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.